1. Home
  2. OPK vs NB Comparison

OPK vs NB Comparison

Compare OPK & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • NB
  • Stock Information
  • Founded
  • OPK 2007
  • NB 1987
  • Country
  • OPK United States
  • NB United States
  • Employees
  • OPK N/A
  • NB N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • NB Metal Mining
  • Sector
  • OPK Health Care
  • NB Basic Materials
  • Exchange
  • OPK Nasdaq
  • NB Nasdaq
  • Market Cap
  • OPK 1.1B
  • NB 930.8M
  • IPO Year
  • OPK 1995
  • NB N/A
  • Fundamental
  • Price
  • OPK $1.52
  • NB $8.11
  • Analyst Decision
  • OPK Buy
  • NB Strong Buy
  • Analyst Count
  • OPK 3
  • NB 3
  • Target Price
  • OPK $2.63
  • NB $5.75
  • AVG Volume (30 Days)
  • OPK 1.9M
  • NB 13.8M
  • Earning Date
  • OPK 11-06-2025
  • NB 11-12-2025
  • Dividend Yield
  • OPK N/A
  • NB N/A
  • EPS Growth
  • OPK N/A
  • NB N/A
  • EPS
  • OPK N/A
  • NB N/A
  • Revenue
  • OPK $664,029,000.00
  • NB N/A
  • Revenue This Year
  • OPK N/A
  • NB N/A
  • Revenue Next Year
  • OPK $0.97
  • NB N/A
  • P/E Ratio
  • OPK N/A
  • NB N/A
  • Revenue Growth
  • OPK N/A
  • NB N/A
  • 52 Week Low
  • OPK $1.11
  • NB $1.27
  • 52 Week High
  • OPK $2.04
  • NB $12.58
  • Technical
  • Relative Strength Index (RSI)
  • OPK 54.40
  • NB 52.52
  • Support Level
  • OPK $1.48
  • NB $6.40
  • Resistance Level
  • OPK $1.56
  • NB $12.58
  • Average True Range (ATR)
  • OPK 0.05
  • NB 1.29
  • MACD
  • OPK -0.01
  • NB -0.08
  • Stochastic Oscillator
  • OPK 34.62
  • NB 28.24

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.

Share on Social Networks: